Search this site :
Accueil
Professionnels de Santé
Patients
BioGaia en France
Professionnels de Santé
/
Preuves cliniques
Current Size:
100%
Revues
Voir documentation afférente (en anglais):
Can Lactobacillus reuteri prevent allergic disease in early childhood?
The Lactobacillus and Bifidobacterium microflora of the human intestine: composition and succession.
Commensal-derived probiotics as anti-inflammatory agents
L. reuteri ATCC 55730 – A clinically proven probiotic
L. reuteri Drops – Novel delivery system.
Validation of the probiotic concept: L. reuteri confers broadspectrum protection against disease in humans and animals
Enhancement of human health with L. reuteri
A Th1/Th2-associated chemokine imbalance preceding allergic disease is influenced by birth size, breastfeeding, day-care and probiotics.
Transferability of a tetracycline resistance gene from probiotic Lactobacillus reuteri to bacteria in the gastrointestinal tract of humans
Antibiotic resistance in Lactobacillus reuteri and Lactobacillus plantarum
IgE-associated allergic disease during infancy is associated with low levels of C-reactive protein at one year of age
Lacobacillus reuteri DSM 17938 in infantile colic: microbiological prospective randomized double blind trial using FISH technique
Influence of dietary supplementation with Lactobacillus reuteri on the oral flora of healthy subjects
Persistence of Lactobacillus reuteri DSM 17938 in the Human Intestinal Tract
Efficacy of oral supplementation with Lactobacillus reuteri in infants weighing less than 1500g in modifying the intestinal colonisation by Gram-negative bacteria
Preuves cliniques
La diarrhée aigüe
La diarrhée associée aux antibiotiques (DAA)
Recherche fondamentale
Aspects qualitatifs et forme galénique
La colique infantile ou colique du nourrisson
Revues
Une flore intestinale équilibrée
Helicobacter pylori
Autres thèmes de recherche clinique
Les Produits BioGaia en France
